Market Snapshot: Global Sleep Apnea Management Market Will Reach $10.3Bn by 2022
Executive Summary
The worldwide airway management accessories and sleep apnea management products market is expected to reach $10.3bn by 2022, a CAGR of 7.4%. This market is largely driven by the rising prevalence of age- and obesity-related respiratory disorders, the rising demand for at-home patient care and rapid growth of sleep apnea treatment device sales. The three major players are Philips Healthcare, ResMed and Drive DeVilbiss.
You may also be interested in...
Exec Chat: ResMed's CEO Mick Farrell Outlines 2025 Strategy For 250 Million Users
ResMed's CEO Mick Farrell outlined the company's 2025 strategy: double-digit growth, drive up its user base to 250 million people and becoming the leading digital health company in both sleep apnea and chronic obstructive pulmonary (COPD) disease. Medtech Insight sat down with Farrell at ResMed's San Diego headquarters to learn more.
Menopause Research To Benefit From White House Initiative To Bolster Women’s Health
Women’s health leaders in the menopause space have high hopes that President Biden’s executive order will provide dollars for more research on how hormone therapy can prevent disease and draw attention to the need for provider education on menopausal symptoms.
BD’s CTO Beth McCombs Discusses Key Initiatives – AI/Gen AI; DE&I Strategy; Succession Planning
BD CTO Beth McCombs discusses her role in driving innovation, including the integration of AI and generative AI to create efficiencies, and passion for creating a culture of inclusion, diversity and equity.